Elevated STIL predicts poor prognosis in patients with hepatocellular carcinoma

被引：1
|
作者：
Song, Huangqin [1 ,2 ,3 ,4 ]
Zhao, Haichao [1 ,2 ,3 ,4 ]
Chen, Changzhou [3 ,4 ]
Zhang, Donglin [1 ,2 ,3 ,4 ]
Wang, Xiaoxiao [1 ,2 ,3 ,4 ]
He, Jiefeng [1 ,2 ,3 ,4 ,5 ,6 ]
机构：
[1] Shanxi Med Univ, Shanxi Bethune Hosp, Tongji Shanxi Hosp, Shanxi Acad Med Sci,Hosp 3, Taiyuan, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Dept Liver Surg & Transplantat, Shanghai, Peoples R China
[3] Fudan Univ, Key Lab Carcinogenesis & Canc Invas, Minist Educ, Shanghai, Peoples R China
[4] Fudan Univ, Inst Biomed Sci, Shanghai, Peoples R China
[5] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China
[6] Shanxi Med Univ, Shanxi Bethune Hosp, Tongji Shanxi Hosp, Shanxi Acad Med Sci,Hosp 3, Taiyuan 030032, Peoples R China
来源：
MEDICINE | 2023年 / 102卷 / 07期
关键词：
hepatocellular carcinoma; immune infiltrates analyses; STIL; T-CELLS; CANCER;
D O I：
10.1097/MD.0000000000033004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Overexpression of SCL/TAL1 interrupting locus (STIL) has been observed in various cancer types. However, the clinical significance of STIL in hepatocellular carcinoma (HCC) remains unknown. Cox regression and Kaplan-Meier survival analyses were performed to evaluate the prognostic value of STIL. Go and Kyoto encyclopedia of genes and genomes (KEGG) enrichment analyses were also carried out. Immune infiltrates analyses were conducted based on TIMER (Tumor Immune Estimation Resource) and GAPIA databases. STIL expression was highly expressed in HCC tissues, based on multiple databases. KEGG and GO enrichment analysis showed STIL-related to tumorigenesis and progress. Furthermore, STIL was significantly correlated with immune infiltration. STIL serves as a biomarker for the prediction of patient survival.
引用
收藏
页数：8
相关论文
共 50 条
  • [41] Expression of prothymosin α predicts early recurrence and poor prognosis of hepatocellular carcinoma
    Sang Yun Ha
    Dae Hyun Song
    Soo Hyun Hwang
    Soo Youn Cho
    Cheol-Keun Park
    Hepatobiliary & Pancreatic Diseases International, 2015, 14 (02) : 171 - 177
  • [42] High expression of the TEFM gene predicts poor prognosis in hepatocellular carcinoma
    Fei, Zai-Yi
    Wang, Wei-Si
    Li, Su-Fen
    Zi, Jia-Ji
    Yang, Li
    Liu, Ting
    Ao, Song
    Liu, Qian-Qian
    Cui, Qing-Hua
    Yu, Min
    Xiong, Wei
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 11 (06) : 1291 - 1304
  • [43] Methylation of PCDH19 predicts poor prognosis of hepatocellular carcinoma
    Zhang, Ting
    Guan, Guiwen
    Chen, Tingting
    Jin, Jingling
    Zhang, Lichun
    Yao, Mingjie
    Qi, Xuewei
    Zou, Jun
    Chen, Jiacheng
    Lu, Fengmin
    Chen, Xiangmei
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 (05) : e352 - e358
  • [44] CCL15 overexpression predicts poor prognosis for hepatocellular carcinoma
    YueGuo Li
    Hai Peng Yu
    Peng Zhang
    Hepatology International, 2016, 10 : 488 - 492
  • [45] Elevated RGMA Expression Predicts Poor Prognosis in Patients with Glioblastoma
    Thi Le Phan
    Kim, Hyun-Jin
    Lee, Suk Jun
    Choi, Moon-Chang
    Kim, Sung-Hak
    ONCOTARGETS AND THERAPY, 2021, 14 : 4867 - 4878
  • [46] A 7 GENE SET ASSOCIATED WITH CHRONIC HYPDXIA PREDICTS POOR PROGNOSIS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
    van Malenstein, H.
    Verslype, C.
    Gevaert, O.
    Libbrecht, L.
    Daemen, A.
    Allemeersch, J.
    Nevens, F.
    Van Cutsem, E.
    Cassiman, D.
    De Moor, B.
    van Pelt, J.
    ANNALS OF ONCOLOGY, 2010, 21 : 30 - 30
  • [47] Down-regulated of PCDH10 predicts poor prognosis in hepatocellular carcinoma patients
    Bing, Yuntao
    Tian, Maolin
    Li, Gang
    Jiang, Bin
    Ma, Zhaolai
    Li, Lei
    Wang, Liang
    Wang, Hangyan
    Xiu, Dianrong
    MEDICINE, 2018, 97 (35)
  • [48] High TGF-β1 expression predicts poor disease prognosis in hepatocellular carcinoma patients
    Peng, Li
    Yuan, Xiao-Qing
    Zhang, Chao-Yang
    Ye, Fei
    Zhou, Hui-Fang
    Li, Wen-Ling
    Liu, Zhao-Yang
    Zhang, Ya-Qin
    Pan, Xi
    Li, Guan-Cheng
    ONCOTARGET, 2017, 8 (21) : 34387 - 34397
  • [49] Increased CMTM4 mRNA expression predicts a poor prognosis in patients with hepatocellular carcinoma
    He-Qi Zhou
    Jian-Hao Li
    Li-Wen Liu
    Jia-Min Lou
    Zhi-Gang Ren
    Hepatobiliary & Pancreatic Diseases International, 2020, 19 (06) : 596 - 601
  • [50] Elevated serum visfatin levels are associated with poor prognosis of hepatocellular carcinoma
    Sun, Yifan
    Zhu, Shengbo
    Wu, Zhitong
    Huang, Yiyong
    Liu, Chunming
    Tang, Shifu
    Wei, Lili
    ONCOTARGET, 2017, 8 (14) : 23427 - 23435
12345